SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-13-001412
Filing Date
2013-04-22
Accepted
2013-04-22 14:05:11
Documents
5
Period of Report
2013-04-18
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_041813.htm 8-K 27078
2 NOTICE TO SERIES B WARRANT HOLDERS, DATED APRIL 5, 2013 ex10-30.htm EX-10.30 23876
3 AMENDMENT 3 TO WARRANT AGREEMENT, DATED APRIL 18, 2013 ex10-31.htm EX-10.31 20157
4 PRESS RELEASE ex99-1.htm EX-99.1 13189
5 logo.jpg GRAPHIC 5563
  Complete submission text file 0001387131-13-001412.txt   93381
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-88480 | Film No.: 13773441
SIC: 2834 Pharmaceutical Preparations